Abstract

Signaling pathways act as relay systems that drive how biological systems respond to specific environmental cues. These cues act as regulators of how cells undergo biological processes like development and normal tissue homeostasis among others. Errors in environmental cues or the ability of cells to respond to such cues leads to erroneous cellular behavior and potentially disease states like cancer. Accordingly, insghts into cell-signaling and processing can be instrumental in design of effective therapies against malignancies. A central paradigm of signaling pathways is that ligands bind to and activate cell-membrane bound receptors, which in turn leads to activation of intracellular cascades. However, to target receptor mediated signaling effectively, it may not be enough to understand the biology of the target receptor in isolation. Interactions with other receptors of the same receptor tyrosine kinase (RTK) family or other families might be critical for understanding the signaling diversity of a particular pathway from the systems perspective. For instance, the role of kinase-dead ErbB3 receptor in the regulation of EGFR and ErbB2 has been critical for a deeper understanding of the ErbB-pathway Along similar lines, heparan sulfate glycosaminoglycans (HSGAGs) have been shown to serve as co-receptors essential for signaling through cell-surface interactions on multiple receptors such as MET and FGFRs. We have recently investigated signaling responses in the FGFR system and found a thus far unappreciated signaling mechanism. We have leveraged a data-driven mechanistic modeling approach to examine the role of FGF2-dependent FGFR signaling driven by FGF2-HSGAG-FGFR1 trimeric complexes. The insights gained from this work can be useful for targeting the FGFR pathway but also to reveal greater insights into the fundamental principles of signaling pathway regulation by HSGAGs in general.

Highlights

  • Binding on monomeric ligand to monomeric receptors leads to Michaelis-Menten type activation of intracellular signaling cascades

  • As the concentration of extracellular ligand increases from low to high, larger fraction of receptor gets activated until the ligand concentration becomes high enough such that receptor activation is saturated

  • An in-depth investigation of the model indicates that ligands like FGF2 elicit biphasic responses owing to the ternary interactions between FGF2, heparan sulfate glycosaminoglycans (HSGAGs) and FGFRs on the surface of the cell

Read more

Summary

Introduction

Binding on monomeric ligand to monomeric receptors leads to Michaelis-Menten type activation of intracellular signaling cascades. One would expect that cellular responses to signaling pathway activation follow Michaelis-Menten type kinetics. From low to intermediate concentrations of FGF-ligands, cellular response increases but decreases from intermediate to high concentrations of FGF-ligand.

Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call